Quantcast

Latest Molecular genetics Stories

2014-01-13 04:21:08

New Preclinical Results in Non-Human Primates Demonstrate Significant and Sustained Reduction of Transthyretin Using its Proprietary LUNARTM Delivery Technology SAN DIEGO, Jan. 13, 2014 /PRNewswire/ -- Arcturus Therapeutics, Inc., an industry leader in RNA technologies, today announced its flagship program - an RNAi therapeutic targeting transthyretin (TTR)-mediated amyloidosis. Preclinical non-human primate data will be presented at the Biotech Showcase being held January 13, 2014...

2014-01-10 08:23:49

SEATTLE, Jan. 10, 2014 /PRNewswire/ -- PhaseRx, Inc., an RNA therapeutics company, today announced the appointment of Michael Houston, Ph.D., as its Vice President, Therapeutics Development. (Logo: http://photos.prnewswire.com/prnh/20140110/SF44129LOGO) Dr. Houston brings more than two decades of experience in the manufacturing and development of peptide and oligonucleotide-based therapeutics to PhaseRx. He has directed numerous programs ranging from research to GMP manufacture of...

2014-01-08 23:02:56

National Institute of Mental Health Director Salutes UVA Discovery Charlottesville, VA (PRWEB) January 08, 2014 For the second year in a row, groundbreaking research from the University of Virginia School of Medicine’s Department of Biochemistry and Molecular Genetics has made the list of the year’s top 10 discoveries and breakthroughs, as compiled by the director of the National Institute of Mental Health. Under the heading “Brain Exceptionalism,” NIMH Director Thomas R. Insel,...

2014-01-06 08:26:25

CAMBRIDGE, Mass., Jan. 6, 2014 /PRNewswire/ -- Moderna Therapeutics, the pioneer in developing messenger RNA (mRNA) Therapeutics(TM), a revolutionary new treatment modality to enable the in vivo production of therapeutic proteins, announced today that President and founding Chief Executive Officer Stephane Bancel will present a company overview at the 32(nd) Annual J.P. Morgan Healthcare Conference. Bancel will focus on the potential of Moderna's mRNA therapeutics to transform drug...

2013-12-19 23:23:22

St. George’s to Utilize DNA2.0’s GeneGPS® Expression Technology to Increase Protein Expression in Tobacco for the Production of Therapeutic Antibodies Menlo Park, Calif. (PRWEB) December 19, 2013 DNA2.0 has entered into a research collaboration with the Infection and Immunity Research Centre at St. George’s, University of London, to support the development of plant-based biopharmaceuticals. Professor Julian Ma and his research group at St. George’s have made significant...

2013-12-17 23:04:19

CSO to Present Data on the Recently Launched SURE CHO-Mplus™ Libraries Geneva, Switzerland (PRWEB) December 17, 2013 Selexis SA, a serial innovation company focused on drug discovery for lead identification and cell line development for scale-up and manufacturing of therapeutic protein drugs announced today data from the Company’s SURE CHO-Mplus™ Libraries will be presented at the 13th Annual PepTalk Conference, January 13-17, 2014 at the Renaissance Hotel & Palm Springs...

Technique Accelerates Gene Discovery
2013-12-13 08:05:12

redOrbit Staff & Wire Reports - Your Universe Online Researchers working to decipher the role of genes since the completion of the Human Genome Project may see their efforts accelerated by a new approach that lets them permanently and selectively delete genes from a cell's DNA. The new system, known as CRISPR, was developed by researchers at MIT, the Broad Institute, and the Whitehead Institute, and should allow scientists to study the entire genome at once. In two new papers...

Researchers Show B Cells Can Deliver Potentially Therapeutic Bits Of Modified RNA
2013-11-26 06:59:03

University of California - San Diego Researchers at the University of California, San Diego School of Medicine have successfully targeted T lymphocytes – which play a central role in the body's immune response – with another type of white blood cell engineered to synthesize and deliver bits of non-coding RNA or microRNA (miRNA). The achievement in mice studies, published in this week's online early edition of the Proceedings of the National Academy of Sciences, may be the first step...


Word of the Day
cock-a-hoop
  • Exultant; jubilant; triumphant; on the high horse.
  • Tipsy; slightly intoxicated.
This word may come from the phrase 'to set cock on hoop,' or 'to drink festively.' Its origin otherwise is unclear. A theory, according to the Word Detective, is that it's a 'transliteration of the French phrase 'coq a huppe,' meaning a rooster displaying its crest ('huppe') in a pose of proud defiance.' Therefore, 'cock-a-hoop' would 'liken a drunken man to a boastful and aggressive rooster.'
Related